Emerald Advisers, LLC Incyte Corp Transaction History

Emerald Advisers, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$76.02 - $100.5 $143,981 - $190,347	-1,894 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$80.74 - $97.7 $188,850 - $228,520	-2,339 Reduced 55.26%	1,894 $165,000
Q3 2020 Oct 28, 2020	SELL	$85.07 - $109.69 $7,230 - $9,323	-85 Reduced 1.97%	4,233 $380,000
Q2 2020 Jul 28, 2020	SELL	$74.18 - $108.93 $16,616 - $24,400	-224 Reduced 4.93%	4,318 $449,000
Q1 2020 Apr 30, 2020	SELL	$63.18 - $85.97 $351,407 - $478,165	-5,562 Reduced 55.05%	4,542 $333,000
Q4 2019 Jan 29, 2020	SELL	$73.04 - $95.72 $8,910 - $11,677	-122 Reduced 1.19%	10,104 $882,000
Q3 2019 Oct 31, 2019	SELL	$72.82 - $86.52 $161,296 - $191,641	-2,215 Reduced 17.8%	10,226 $759,000
Q2 2019 Jul 31, 2019	SELL	$73.52 - $88.7 $177,256 - $213,855	-2,411 Reduced 16.23%	12,441 $1.06 Million
Q1 2019 May 01, 2019	BUY	$63.56 - $88.17 $177,332 - $245,994	2,790 Added 23.13%	14,852 $1.28 Million
Q4 2018 Jan 30, 2019	BUY	$58.5 - $69.94 $705,627 - $843,616	12,062 New	12,062 $767,000
Q4 2017 Feb 05, 2018	SELL	$93.56 - $116.6 $540,028 - $673,015	-5,772 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$109.15 - $138.27 $630,013 - $798,094	5,772	5,772 $674,000

652

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.